- Home
- RNP vs INMD Comparison
RNP vs INMD Comparison
Compare RNP & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RNP | INMD |
|---|---|---|
| Founded | 2003 | 2008 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 959.9M | 879.2M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | RNP | INMD |
|---|---|---|
| Price | $21.66 | $14.48 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $16.75 |
| AVG Volume (30 Days) | 117.6K | ★ 1.4M |
| Earning Date | 01-01-0001 | 02-10-2026 |
| Dividend Yield | ★ 7.94% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.43 |
| Revenue | N/A | ★ $370,495,000.00 |
| Revenue This Year | N/A | $5.40 |
| Revenue Next Year | N/A | $4.80 |
| P/E Ratio | ★ N/A | $10.00 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $15.52 | $13.14 |
| 52 Week High | $21.27 | $19.78 |
Technical Indicators
Market Signals| Indicator | RNP | INMD |
|---|---|---|
| Relative Strength Index (RSI) | 77.84 | 46.62 |
| Support Level | $20.64 | $14.23 |
| Resistance Level | $21.23 | $14.55 |
| Average True Range (ATR) | 0.28 | 0.54 |
| MACD | 0.12 | -0.13 |
| Stochastic Oscillator | 98.36 | 12.30 |
Price Performance
Historical ComparisonAbout RNP Cohen & Steers REIT and Preferred and Income Fund Inc.
Cohen & Steers REIT and Preferred Income Fund Inc is a diversified, closed-ended investment management fund. Its investment objective is to provide high current income with capital appreciation as its secondary objective. The Fund invests at least its total assets in common stocks issued by real estate investment trusts (REITs) and preferred securities under normal circumstances.
About INMD InMode Ltd.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.